1. Positioning of proteasome inhibitors in therapy of solid malignancies
   Margot S. F. Roeten et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
2. Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
   Zheng Zheng et al, 2023, Experimental and Therapeutic Medicine CrossRef
3. Research progress on therapeutic targeting of quiescent cancer cells
   Jinhua Zhang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
4. The cilia-regulated proteasome and its role in the development of ciliopathies and cancer
   Christoph Gerhardt et al, 2016, Cilia CrossRef
5. Control of Hedgehog Signalling by the Cilia-Regulated Proteasome
   Christoph Gerhardt et al, 2016, Journal of Developmental Biology CrossRef
6. Fe3O4 magnetic nanoparticle-enhanced radiotherapy for lung adenocarcinoma via delivery of siBIRC5 and AS-ODN
   Shuzhen Chen et al, 2021, Journal of Translational Medicine CrossRef
7. The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity
   Mengyun Zhang et al, 2023, Biomedicines CrossRef
8. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
   G.R. Tundo et al, 2020, Pharmacology & Therapeutics CrossRef
9. First-principles study of V3+ adsorption on MXene toward vanadium redox flow battery
   Qiang Li et al, 2023, Computational and Theoretical Chemistry CrossRef